The Company has been advised by Pink OTC Markets, Inc., which operates an electronic quotation service for securities traded over-the-counter ("OTC"), that its securities are immediately eligible for quotation on the OTCQB. The OTCQB is a market tier for OTC-traded companies that are registered and reporting with the Securities and Exchange Commission. The Company has also been advised that its shares will trade under the symbol ANPI. Investors will be able to view real-time stock quotes for ANPI at www.otcmarkets.com.
Angiotech's common shares will still be tradable on the Toronto Stock Exchange under the trading symbol "ANP".
Forward Looking Statements
Statements contained in this press release that are not based on
historical fact, including without limitation statements containing the
words "believes," "may," "plans," "will," "estimates," "continues,"
"anticipates," "intends," "expects" and similar expressions, constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995 and constitute
"forward-looking information" within the meaning of applicable Canadian
securities laws. All such statements are made pursuant to the "safe
harbor" provisions of applicable securities legislation. Forwardlooking
statements may involve, but are not limited to, comments with respect
to our objectives and priorities for the remainder of 2010 and beyond,
our strategies or future actions, our targets, expectations for our
financial condition and the results of, or outlook for, our operations,
research and development and product and drug development. Such
forwardlooking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
events or developments to be materially different from any future
results, events or developments expressed or implied by such
forward-looking statements. Many such known risks, uncertainties and
other factors are taken into account as part of our assumptions
underlying these forward-looking statements and include, among others,
the following: general economic and business conditions in
Given these uncertainties, assumptions and risk factors, investors are cautioned not to place undue reliance on such forward-looking statements. Except as required by law, we disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained in this press release to reflect future results, events or developments.
(C)2011 Angiotech Pharmaceuticals, Inc. All Rights Reserved.
About Angiotech Pharmaceuticals
Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and
medical device company. Angiotech discovers, develops and markets
innovative treatment solutions for diseases or complications associated
with medical device implants, surgical interventions and acute injury.
To find out more about Angiotech (OTCQB: ANPI, TSX: ANP), please visit
our website at www.angiotech.com.
About Pink OTC Markets Inc.
Pink OTC Markets Inc. is a financial information and technology services
company that operates an inter-dealer electronic quotation and trading
system in the Over-the-Counter, or OTC, securities market. It is not
registered with the Securities and Exchange Commission as a stock
exchange or a broker-dealer firm. Investors should contact a
broker-dealer firm to trade in a security quoted on the OTCQB or the
other OTC tiers operated by Pink OTC Markets Inc. More information is
available at www.otcmarkets.com.
SOURCE Angiotech Pharmaceuticals, Inc.